|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 5/107 | |
| C07K 5/103 | |||
| A61K 47/54 | |||
| A61K 47/60 | |||
| A61K 47/64 | |||
| A61K 47/65 |
| (11) | Number of the document | 3302516 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16804090.5 |
| Date of filing the European patent application | 2016-05-27 | |
| (97) | Date of publication of the European application | 2018-04-11 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/034517 |
| Date | 2016-05-27 |
| (87) | Number | WO 2016/196243 |
| Date | 2016-12-08 |
| (30) | Number | Date | Country code |
| 201562168244 P | 2015-05-29 | US | |
| 201562235833 P | 2015-10-01 | US |
| (72) |
CARLSON, Jeffrey, C., US
BLOKHIN, Andrei, V., US
|
| (73) |
Arrowhead Pharmaceuticals, Inc.,
177 E. Colorado Boulevard, Suite 700, Pasadena, CA 91105,
US
|
| (54) | BIOLOGICALLY CLEAVABLE TETRAPEPTIDE LINKING AGENTS |
| BIOLOGICALLY CLEAVABLE TETRAPEPTIDE LINKING AGENTS |